NINVIPI Trademark

Trademark Overview

On Tuesday, March 1, 2016, a trademark application was filed for NINVIPI with the United States Patent and Trademark Office. The USPTO has given the NINVIPI trademark a serial number of 86924969. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 15, 2020. This trademark is owned by Bristol-Myers Squibb Company. The NINVIPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
ninvipi

General Information

Serial Number86924969
Word MarkNINVIPI
Filing DateTuesday, March 1, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 15, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 5, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, June 15, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 15, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, November 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019EXTENSION 5 GRANTED
Wednesday, October 30, 2019EXTENSION 5 FILED
Thursday, October 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 30, 2019TEAS EXTENSION RECEIVED
Saturday, May 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2019EXTENSION 4 GRANTED
Thursday, May 2, 2019EXTENSION 4 FILED
Thursday, May 2, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 2, 2018EXTENSION 3 GRANTED
Friday, November 2, 2018EXTENSION 3 FILED
Friday, November 2, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2018EXTENSION 2 GRANTED
Wednesday, May 9, 2018EXTENSION 2 FILED
Wednesday, May 9, 2018TEAS EXTENSION RECEIVED
Friday, November 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2017EXTENSION 1 GRANTED
Wednesday, November 1, 2017EXTENSION 1 FILED
Wednesday, November 1, 2017TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017ASSIGNED TO LIE
Wednesday, December 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 21, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, June 21, 2016PRIORITY ACTION E-MAILED
Tuesday, June 21, 2016PRIORITY ACTION WRITTEN
Tuesday, June 14, 2016ASSIGNED TO EXAMINER
Saturday, March 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ninvipi diseases pharmaceutical human anti preparations disorders organ solid auto immune